UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000051061
Receipt number R000058225
Scientific Title Evaluation study for intake of cyclic dipeptide on improvements in cognitive function
Date of disclosure of the study information 2023/05/22
Last modified on 2023/05/15 15:08:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation study for intake of cyclic dipeptide on improvements in cognitive function

Acronym

Evaluation study for intake of cyclic dipeptide on improvements in cognitive function

Scientific Title

Evaluation study for intake of cyclic dipeptide on improvements in cognitive function

Scientific Title:Acronym

Evaluation study for intake of cyclic dipeptide on improvements in cognitive function

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate improvements in cognitive function by taking cyclic dipeptide

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

RBANS
Cognitrax
(before and 12 weeks after intake)

Key secondary outcomes

SF-36v2
WHO-5J
body mass and BMI
blood pressure, pulsation
subjects' diary
doctor's questions
(before and 12 weeks after intake)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Intake cyclic dipeptide for 12 weeks

Interventions/Control_2

Intake placebo for 12 weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

60 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Japanese males and females aged 60 to 75 years oldĀ at the time of informed consent
2) Subjects who feel that they are more forgetful compared with their younger days

Key exclusion criteria

1) Subjects judged inappropriate for the study by the principal
2) Subjects who are participating in other clinical trials
3) Subjects who are taking medicines that can affect the test result
4) Subjects who are taking supplements that can affect the test result
5) Subjects who took RBANS by 3 months before the start of the test
6) Subjects who can be allergic to the test food
7) Subjects who have had a stroke, subarachnoid hemorrhage, cerebral infarction, cerebral hemorrhage, cerebral contusion, or head injury resulting in hospitalization for treatment or surgery
8) Excessive tobacco and alcohol users and those with extremely irregular eating habits
9) Subjects with medical history of hepatitis
10) Subjects with severe anemia
11) Subjects with medical history or medical treatments of Epileptic seizures, diabetes, thyroid dysfunction, or severe renal dysfunction (hemodialysis, uremia, anuria)
12) Subjects who have taken neuropsychological tests in the hospital

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Takashi
Middle name
Last name Koikeda

Organization

Shiba Palace Clinic

Division name

Chair

Zip code

105-0013

Address

DaiwaA Hamamatsucho Bldg. 6F, 1-9-10, Hamamatsucho, Minato-ku, Tokyo, 105-0013, JAPAN

TEL

03-5408-1590

Email

jimukyoku@mail.souken-r.com


Public contact

Name of contact person

1st name Miwa
Middle name
Last name Kaneko

Organization

SOUKEN Co., Ltd

Division name

Management Division

Zip code

105-0013

Address

DaiwaA Hamamatsucho Bldg. 3F, 1-9-10, Hamamatsucho, Minato-ku, Tokyo, 105-0013, JAPAN

TEL

03-5408-1555

Homepage URL


Email

m_kaneko@mail.souken-r.com


Sponsor or person

Institute

Shiba Palace Clinic

Institute

Department

Personal name



Funding Source

Organization

JELLICE

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shiba Palace Clinic Ethics Review Committee

Address

DaiwaA Hamamatsucho Bldg. 6F, 1-9-10, Hamamatsucho, Minato-ku, Tokyo, 105-0013, JAPAN

Tel

03-5408-1599

Email

shiba_palace@s-palace-clinic.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 05 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2023 Year 04 Month 27 Day

Date of IRB

2023 Year 05 Month 11 Day

Anticipated trial start date

2023 Year 05 Month 15 Day

Last follow-up date

2023 Year 11 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 05 Month 15 Day

Last modified on

2023 Year 05 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000058225


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name